Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers
Tekla Hornakova(Ludwig Cancer Research), Jean‐Christophe Renauld(Ludwig Cancer Research)
Cited by 65
Related Papers
Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line
|Journal of Biological Chemistry|2002|472
Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types
|The Journal of Immunology|2001|400
Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors
|Haematologica|2011|77